National Institute of Food and Drug Safety Evaluation

Kwangcheonkim Co., South Korea’s largest seaweed producer with a history spanning over 50 years, is up for grabs in a deal that could fetch up...

Jollibee Foods Corp., a household name in Southeast Asia’s food market, has been named the preferred buyer of Norang Tongdak, a South Korean f...

South Korea’s food exports climbed 10% on-year to $7.26 billion in 2024, led by ramen, ready-to-eat meals and seasoned seaweed, according to g...

South Korea’s processed food exports are expected to reach 6 trillion won ($4.4 billion) this year after Korean food companies have aggressive...

SK Earthon Co., the petroleum exploration and production (E&P) unit of South Korea’s top energy company SK Innovation Co., has secured rig...

Samsung Biologics Co., the world’s largest contract drugmaker, will undergo a strategic split to separate its contract development and manufac...

Chiefs of South Korea’s major financial groups – Shinhan, Woori and iM – are ramping up global investor outreach with new sharehol...

South Korea’s Hanwha Group has completed the acquisition of the country’s No. 2 food service and catering company Ourhome Ltd. for 869.5...

Chung Yong-jin, chairman of South Korea’s retail group Shinsegae Inc., is the only Korean businessperson accompanying US President Donald Trum...

South Korea has officially requested that the US take a distinct approach in its ongoing probe into foreign semiconductor technology and related dow...

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea’s processed food exports to India have surged to a record 6 trillion won ($4.1 billion), marking a significant milestone in the gr...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

The South Korean defense industry's current heyday is expected to continue for a while as global demand for Korean-made weapons and combat systems h...

South Korea’s National Pension Service, the country’s largest institutional investor, has come to the rescue of the domestic stock marke...

South Korea’s National Pension Service (NPS), the country’s largest institutional investor, is set to overhaul its investment strategy w...

South Korean shipbuilding stocks soared on Friday on news that US President Donald Trump indicated that the world’s No. 1 economy may purchase...

Spot, a quadruped robot developed by Boston Dynamics Inc., will aid defense and safety agencies in Australia, New Zealand and Indonesia to assist in...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

It is time to shift focus toward non-US markets after years of stellar performance of US assets driven by the robust world’s No. 1 economy, sa...

Orchestra Private Equity has begun the process of divesting the South Korean operations of fast-food chain KFC, which has seen earnings growth since...

South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

South Korea’s top and third-ranked food delivery apps, Baedal Minjok (Baemin) and Yogiyo, saw their biggest-ever monthly drops in transaction ...

WASHINGTON, D.C. – The US government plans to unveil country-specific reciprocal tariffs on April 2, with particular attention to nations impo...

South Korean biotechnology firm SillaJen Inc. is pioneering a new approach to determine the best dose for a cancer drug combination in clinical tria...

Samsung Group companies will jointly invest $10 million in C2N Diagnostics LLC, a U.S.-based company specializing in blood-based Alzheimer’s d...

South Korea’s National Pension Service (NPS), the nation’s biggest institutional investor, could lose more than 1 trillion won ($692 mil...

Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...